The Lancet· Jasper Boeddinghaus, Paolo Bima, Luca Crisanti, Dagmar I Keller, Ksenija Slankamenac, Michael Christ, Philipp Schuetz, Andrea Wiencierz, Ivo Strebel, Julia Reinhardt, Iryna Vyshnevska, Tzu-Ying Tsao, Maria Pia Ruggieri, Stephan Steuer, Òscar Miró, Veli-Pekka Harjola, Fulvio Morello, Peiman Nazerian, Dominik Roth, José L Zamorano, Deborah E Gannon, Jason Pott, Ben Bloom, Rafique Zubaid, Richina Bicette, Andreea Cuculici, Héctor Bueno, Juan Sanchis, Felix Mahfoud, Mohammed O A Abubakr, Hyun Suk Yang, Christian Mueller, PRESC1SE-MI investigators·· 2026-08-29AI 评分18
急诊科心肌梗死0/1 h路径的安全性与有效性:一项国际、实用性、阶梯楔形、整群随机对照试验
[Articles] Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial
AI 导读
国际阶梯楔形整群随机对照试验显示,急诊科实施0/1 h心肌梗死路径达到预设的30天复合安全性终点非劣效标准,但相比0/3 h路径未缩短急诊科停留时间。在该场景下,单独实施0/1 h路径不应预期改善急诊科周转效率。
来源:The Lancet · thelancet.com